Managers / Q2 2024 · view latest →
Green Alpha Advisors, LLC
CIK 0001439207 · 136 2ND AVENUE, UNIT D, NIWOT, CO, 80544 · 3039937856
Summary
Green Alpha Advisors, LLC reported $124M in U.S.-listed holdings across 138 positions for Q2 2024.
Its largest position, TSM, represents 4.1% of the portfolio.
Compared with Q1 2024, the fund opened 2 new positions and exited 6.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 66.1% · $82M
- REIT · 15.0% · $19M
- Other · 10.1% · $13M
- ADR · 7.9% · $10M
- NY Reg Shrs · 0.6% · $777,351
- Other · 0.3% · $359,633
Quarter-over-Quarter Changes full breakdown →
vs Q1 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GHGUARDANT HEALTH INC | NEW | +7.1K | 7.1K | +$205,279 | $205,279 |
| LI-CYCLE HOLDINGS CORP | NEW | +27.4K | 27.4K | +$179,177 | $179,177 |
| NVDANVIDIA CORPORATION | ADDED | +15.3K | 17.1K | +$484,635 | $2M |
| EXKEXACT SCIENCES CORP | SOLD OUT | −4.5K | 0 | −$308,629 | $0 |
| ARCTARCTURUS THERAPEUTICS HLDGS | SOLD OUT | −8.4K | 0 | −$284,141 | $0 |
| LICYUSDLI-CYCLE HOLDINGS CORP | SOLD OUT | −238.3K | 0 | −$245,452 | $0 |
| NTLAINTELLIA THERAPEUTICS INC | SOLD OUT | −8.0K | 0 | −$219,090 | $0 |
| TXG10X GENOMICS INC | SOLD OUT | −5.7K | 0 | −$214,409 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $102M | 107 | Apr 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $109M | 115 | Jan 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $104M | 102 | Oct 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $105M | 109 | Aug 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $94M | 112 | Apr 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $125M | 147 | Jan 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $127M | 141 | Oct 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $124M | 138 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $138M | 142 | Apr 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $139M | 151 | Jan 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $130M | 156 | Oct 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $152M | 153 | Jul 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $143M | 150 | Apr 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $120M | 144 | Jan 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $118M | 141 | Oct 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $435M | 149 | Jul 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $148M | 136 | Apr 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $148M | 124 | Jan 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $145M | 126 | Oct 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $147M | 127 | Jul 22, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.